Immune privilege of the CNS is not the consequence of limited antigen sampling

Melissa G. Harris, Paul Hulseberg, Changying Ling, Jozsef Karman, Benjamin D. Clarkson, Jeffrey S. Harding, Mengxue Zhang, Adam Sandor, Kelsey Christensen, Andras Nagy, Matyas Sandor, Zsuzsanna Fabry

Research output: Contribution to journalArticlepeer-review


Central nervous system (CNS) immune privilege is complex, and it is still not understood how CNS antigens are sampled by the peripheral immune system under steady state conditions. To compare antigen sampling from immune-privileged or nonprivileged tissues, we created transgenic mice with oligodendrocyte or gut epithelial cell expression of an EGFP-tagged fusion protein containing ovalbumin (OVA) antigenic peptides and tested peripheral anti-OVA peptide-specific sentinel OT-I and OT-II T cell activation. We report that oligodendrocyte or gut antigens are sampled similarly, as determined by comparable levels of OT-I T cell activation. However, activated T cells do not access the CNS under steady state conditions. These data show that afferent immunity is normally intact as there is no barrier at the antigen sampling level, but that efferent immunity is restricted. To understand how this one-sided surveillance contributes to CNS immune privilege will help us define mechanisms of CNS autoimmune disease initiation.

Original languageEnglish (US)
Article number4422
JournalScientific reports
StatePublished - Mar 21 2014

ASJC Scopus subject areas

  • General


Dive into the research topics of 'Immune privilege of the CNS is not the consequence of limited antigen sampling'. Together they form a unique fingerprint.

Cite this